华海药业：4115.23万股限售股9月25日解禁

Core Viewpoint - Huahai Pharmaceutical announced that 41.1523 million restricted shares will be listed for circulation on September 25, 2025, following approval from the China Securities Regulatory Commission [1] Summary by Relevant Sections - Share Issuance Details - The issuance involves 41.1523 million restricted shares, which will be listed for circulation after a 6-month lock-up period [1] - The shares were registered with the China Clearing Shanghai Branch on March 25, 2025 [1] - Shareholder Information - The issuance involves 14 shareholders who have all fulfilled their lock-up commitments [1] - The company has undergone changes in its share capital, including share buybacks and convertible bonds conversion [1] - Regulatory Approval - The issuance has received approval from the China Securities Regulatory Commission, and the sponsoring institution has no objections to the listing of these restricted shares [1]